Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Fibroblast growth factor 21 in non-alcoholic fatty liver disease
HTML
Details
Locations
Year:
2019
Type:
review
Source:
Metabolism
DOI:
10.1016/j.metabol.2019.153994
Authors:
Bradley Tucker,
Huating Li,
Xiaoxue Long,
Kerry-Anne Rye,
Kwok Leung Ong
Institutions:
UNSW Sydney,
Shanghai Jiao Tong University,
Shanghai Sixth People's Hospital
Language:
English
Topic:
Fibroblast Growth Factor Research
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
FGF21,
non-alcoholic fatty liver disease,
nonalcoholic steatohepatitis,
hepatic steatosis,
biomarkers,
hepatic lipid accumulation,
liver inflammation,
hepatocyte ballooning,
therapeutic target
show all 9
SDG:
Good health and well-being
Open Access status:
closed
Funders:
National Heart Foundation of Australia,
National Natural Science Foundation of China,
National Health and Medical Research Council,
National Natural Science Foundation of China-Yunnan Joint Fund
Award:
G3607136392
OpenAlex ID:
W2982370215
FWCI:
1.264
Cites:
131
Cited by:
141
Related to:
10